Abliva

Hadean Venture's Annual Event
2023-10-25 - 2023-10-26 | Oslo, Norway
In October, Abliva’s CEO, Ellen Donnelly, will attend Hadean Venture’s annual event in Oslo.

BioStock Life Science Summit 2023
2023-10-25 - 2023-10-26 | Medicon Village, Scheeletorget 1, Lund, Sweden
In late October, Abliva will attend the BioStock’s Life Science Summit at Medicon Village in Lund.
Magnus Hansson, Abliva’s Chief Medical Officer, will be presenting the company at 09:05 a.m. CET on October 25.
See more details and the link to the event below.

Empower & Inspire - 2nd Annual Leigh Syndrome Symposium
2023-09-19 | Virtual
During World Mitochondrial Disease Week, Abliva’s Chief Medical Officer, Magnus Hansson, will present the company at the Cure Mito Foundation’s Empower & Inspire – 2nd Annual Leigh Syndrome Symposium (virtual).
See below for more information and the link to the event.

Penser South Company Day
2023-09-14 | Malmö, Malmö, Sweden
Our Chief Medical Officer, Magus Hansson, will give a talk at Penser South Company Day in Malmö, on September 14, 2023.
Click the link below for more details and registration.

LSX World Congress USA
2023-09-13 - 2023-09-14 | Hynes Convention Centre, Boston, MA, United States
In September, Abliva will attend the LSX World Congress USA, in Boston, MA.
The event gathers North America’s leading Biotech, Medtech and Healthtech CEOs along with investors, big pharma, and advisors.

The Future of Swedish & Danish Life Science
2023-09-07 | Restaurant Inspira, Scheelevägen 4, Lund, 22363, Sweden
Abliva will participate at the 12th annual edition of ‘The Future of Swedish & Danish Life Science’, on September 7, 2023, in Lund, Sweden.
The company’s Chief Medical Officer, Magnus Hansson, will give a talk entitled Pivotal study design in a rare disease with no regulatory precedent – utilizing patient advocacy groups and registries.
“The Future of Swedish & Danish Life Science offers a dynamic full-day experience with highly relevant seminars, networking and partnering meetings, as well as a lively exhibition. The event annually draws around 500 influential decision-makers representing the pharma, biotech and medtech sectors as well as academia, healthcare, policy makers, regulatory authorities, and financial services.”
Follow the link below for more details.

UMDF’s Mitochondrial Medicine Symposium 2023
2023-06-28 - 2023-07-01 | Sheraton Charlotte Hotel/Le Méridien, 555 SOUTH MCDOWELL STREET, Charlotte, NC, 28204, United States
In late June, Abliva will be attending this year’s international Mitochondrial Medicine Symposium, organized by US patient organization United Mitochondrial Disease Foundation.
The meeting will take place in Charlotte, North Carolina (US), on June 28 – July 1, and includes both scientific as well as patient and family sessions.

Euromit 2023
2023-06-11 - 2023-06-15 | Bologna Congress Center, Piazza della Costituzione, 4/a, Bologna, Italy
In June, Abliva will attend this year’s edition of Euromit – the international conference on mitochondrial disease.
The meeting takes place in Bologna, Italy, and gathers researchers, clinicians, and patients for the sharing of knowledge and insights in the field. The conference also presents opportunities to meet with investigators in our FALCON study with KL1333.

BIO International Convention
2023-06-05 - 2023-06-08 | Boston Convention & Exhibition Center, Boston, MA, United States
In early June, Abliva will attend the BIO International Convention in Boston, US.

ABG Sundal Collier's Life Science Summit Seminar
2023-05-30 - 2023-05-31 | ABG Sundal Collier, Regeringsgatan 25, Stockholm, Sweden
In late May, Abliva will attend and present at ABG Sundal Collier’s Life Science Summit Seminar in Stockholm, Sweden.
The event will also be live-streamed. See below for more info.

Penser Market Bolagsdag
2023-05-25 09:00 - 17:00 (Europe/Stockholm) | Haymarket by Scandic, Hötorget 13-15, Stockholm, 11157, Sweden
On May 25, Abliva will participate at Erik Penser Bank’s Penser Market Bolagsdag in Stockholm.
Abliva’s CMO, Magnus Hansson, will be presenting the company during the morning session.
Further details and link to event below.

Bio€quity Europe 2023
2023-05-14 - 2023-05-16 | MA
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland.
“For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today.”
CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches in Orphan Diseases, at 14:07 GMT.

Kempen Life Science Conference
2023-04-25 - 2023-04-26 | Van Lanschot Kempen, Beethovenstraat 300, Amsterdam, 1077 WZ
In April, we will attend this year’s Kempen Life Science Conference in Amsterdam, Netherlands.

BIO-Europe Spring Digital
2023-03-20 - 2023-03-22 | Virtual
We will digitally attend this year’s BIO-Europe spring, hosted in Basel, Switzerland, on March 20 – 22, 2023.
This major life science and biotech meeting offers a great opportunity for networking and partnering.

BioStock Investor Meeting
2023-03-16 | MA
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023.
CEO Ellen Donnelly will be presenting the company in BioStock’s studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.

Nordic American Life Science Conference 2022
2022-12-07 - 2022-12-08 | Shearman & Sterling, 599 Lexington Ave, New York, NY, United States
In December 2022, Abliva will attend the 7th Annual Nordic American Life Science Conference, hosted by DNB, Nasdaq, and Business Sweden, in New York, US.
Abliva’s CEO Ellen Donnelly will present the company on December 8.

Stora Aktiedagen Stockholm
2022-11-28 - 2022-11-30 | Hotel Birger Jarl, Tulegatan 8, Stockholm, Sweden
In late November, Abliva will attend Aktiespararna’s Stora Aktiedagen Stockholm.
The company’s CEO, Ellen Donnelly, will present the company via Zoom on November 29, 2022, at 7:30 p.m. CET.
See below for detailed information and a link to the event.

Mitochondrial Medicine - Therapeutic Development
2022-11-21 - 2022-11-23 | Wellcome Genome Campus, Hinxton, United Kingdom
In late November, Abliva will attend the annual scientific conference Mitochondrial Medicine – Therapeutic Development in Hinxton, UK.
Abliva’s Chief Medical Officer, Magnus Hansson, will present a poster on one of the important preparatory studies for the upcoming, potentially registrational, Phase 2 study, FALCON, with KL1333 in patients with mitochondrial diseases.

Shareholders' meeting in Tommarp
2022-11-17 18:00 - 20:30 | Tommarps bygdegård, Storgatan 52, Tommarp, Sweden
Abliva will come to Aktiespararna’s local club Sydöstra Skåne, in Tommarp, Sweden, on November 17, 2022.
Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening.
See below for more info and registration.

Shareholders' meeting in Olofström
2022-11-08 18:30 - 20:30 | Olofström, Sweden
Abliva will visit Aktiespararna Västra Blekinge/Bromölla in Olofström on November 8, 2022.
Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening.
See below for more info and registration.

Mitocon's Mitochondrial Diseases Conference
2022-10-07 - 2022-10-08 | Holiday Inn Rome EUR Parco dei Medici, Rome, Italy
In October, Abliva will attend the Italian patient organization Mitocon’s annual Mitochondrial Diseases Conference in Rome, Italy.
On October 8, Abliva’s Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical trials design – presentations and round table discussion.

Nordic Life Science Days 2022
2022-09-28 - 2022-09-29 | Malmömässan, Mässgatan 6, Malmö, 215 32, Sweden
Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022.
CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.

Aktiedagen Lund
2022-09-26 | Elite Hotel Ideon, Scheelevägen 27, Lund, 22363, Sweden
On September 26 (Monday), 2022, Abliva will attend Aktiespararna’s Aktiedagen Lund, at Elite Hotel Ideon.
CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.

Hadean Investor Day
2022-09-21 | Oslo, Norway
More info to come.

mitoNice
2022-09-15 - 2022-09-17 | Nice Acropolis Congress Center, Nice, France
In September, Abliva will attend mitoNice, an international congress dedicated to Mitochondrial Medicine.

Aktiespararna's Digital Temadag - Life Science
2022-08-31 15:00 - 20:40 | Virtual
Abliva will be attending Aktiespararna’s Digital Temadag – Life Science, on Aug 31, 2022.
CEO Ellen Donnelly will present the company at 6:20 p.m. CEST. Follow link below for further information.

Bioblast 2022: Inaugural Conference of Bioenergetics Communications
2022-06-29 - 2022-06-30 | Congress Innsbruck, Rennweg 3, Innsbruck, Austria
On June 29-30, Abliva will participate at Bioblast 2022: Inaugural Conference of Bioenergetics Communications in Innsbruck, Austria.
Abliva’s Communications Officer & Lab Manager, Eleonor Åsander Frostner, will present a summary of the company’s recent preprint publication “Towards a treatment for mitochondrial disease: current compounds in clinical development“.

Fireside Chat in Stockholm
2022-06-21 16:00 - 18:00 | Erik Penser Bank, Apelbergsgatan 27, Stockholm, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Stockholm during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Stockholm, 21 June, 16:00 – 18:00 p.m. CEST:
Erik Penser Bank, Apelbergsgatan 27.
Please respond to anmalan@abliva.com to reserve your space.

Fireside Chat in Lund
2022-06-20 16:00 - 18:00 | Restaurang Inspira, Scheeletorget 1, Lund, Sweden
In light of our recent announcement and the continued developments in the company, we would like to invite shareholders and interested investors to an informal gathering to hear more about the path forward directly from Ellen Donnelly (CEO) and the Abliva team. We hope you will join us in Lund during the Midsummer week to hear an update on the company, learn more about the ongoing rights issue, and ask your most pressing questions.
The event is free of charge, and wine and snacks will be served. As seats are limited, please respond quickly to reserve your space.
Lund, 20 June, 16:00 – 18:00 p.m. CEST:
Restaurang Inspira, Medicon Village, Scheeletorget 1.
Please respond to anmalan@abliva.com to reserve your space.

UMDF's Mitochondrial Medicine Symposium
2022-06-08 - 2022-06-11 | JW Marriott Phoenix Desert Ridge Resort & Spa, Phoenix, AZ, United States
Abliva will participate at the United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium in Phoenix, Arizona.
Abliva’s CMO, Magnus Hansson, will participate in a panel discussion on clinical trials together with Baylor College of Medicine, Cyclerion Therapeutics, and Khondrion, on Friday June 10.
